Schistosoma mansoni infection as a trigger to collapsing glomerulopathy in a patient with high-risk APOL1 genotype

Imagem de Miniatura
Arquivos
art_NEVES_Schistosoma_mansoni_infection_as_a_trigger_to_collapsing_2020.PDF (853.19 KB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
TESTAGROSSA, Leonardo A.
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.14, n.10, article ID e0008582, 7p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Author summary Schistosomiasis mansoni is still a public health problem in Brazil and renal involvement is described. In such cases, a glomerulopathy is the typical manifestation, most often membranoproliferative glomerulonephritis. In the current article, we report a patient with a recent diagnosis of hepatosplenic SM who was admitted for nephrotic syndrome associated with reduced renal function and hypertension. Kidney biopsy established the diagnosis of collapsing glomerulopathy (CG) and molecular genetics investigation identified a high-risk APOL1 genotype (HRG). Of note, HRG has been associated with increased risk to develop CG, and a two-hit model has been proposed for the genesis of this glomerulopathy. According to this model, a HRG represents the increased-susceptibility component, while an infection or other environmental factors could act as triggers for the development of CG. Based on those data and model, our case raises SM infection as a new trigger for this severe form of glomerulopathy. This is the first description of a case of CG associated with SM in a patient with an HRG. This case corroborates the interactive role between genetic and environmental factors in the pathogenesis of CG but also identifies SM infection as an additional trigger for its development. Background Schistosoma mansoni schistosomiasis (SM) remains a public health problem in Brazil. Renal involvement is classically manifested as a glomerulopathy, most often membranoproliferative glomerulonephritis or focal and segmental glomerulosclerosis. We report a case of collapsing glomerulopathy (CG) associated with SM and high-risk APOL1 genotype (HRG). Case report A 35-year-old male was admitted for hypertension and an eight-month history of lower-limb edema, foamy urine, and increased abdominal girth. He had a recent diagnosis of hepatosplenic SM, treated with praziquantel, without clinical improvement. Laboratory tests revealed serum creatinine 1.89mg/dL, blood urea nitrogen (BUN) 24mg/dL, albumin 1.9g/dL, cholesterol 531mg/dL, low-density lipoprotein 426mg/dL, platelets 115000/mm(3), normal C3/C4, antinuclear antibody (ANA), rheumatoid factor (RF), and antineutrophil cytoplasmic antibodies (ANCA), negative serologies for hepatitis C virus (HCV) and human immunodeficiency virus (HIV), HBsAg negative and AntiHBc IgG positive, no hematuria or leukocyturia, 24 hour proteinuria 6.56g and negative serum and urinary immunofixation. Kidney biopsy established the diagnosis of CG. A treatment with prednisone was started without therapeutic response, progressing to end-stage kidney disease 19 months later. Molecular genetics investigation revealed an HRG. Conclusions This is the first report of CG associated with SM in the setting of an HRG. This case highlights the two-hit model as a mechanism for CG pathogenesis, where the high-risk APOL1 genotype exerts a susceptibility role and SM infection serves as a trigger to CG.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/39061
Referências
  1. Albaqumi M, 2008, J AM SOC NEPHROL, V19, P1276, DOI 10.1681/ASN.2007080926
  2. Barsoum R, 2004, KIDNEY INT, V66, P2472, DOI 10.1111/j.1523-1755.2004.66042.x
  3. Barsoum RS, 2013, J ADV RES, V4, P433, DOI 10.1016/j.jare.2013.01.005
  4. BARSOUM RS, 1993, KIDNEY INT, V44, P1, DOI 10.1038/ki.1993.205
  5. Besse W, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0330-7
  6. Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027
  7. Chang JH, 2019, AM J KIDNEY DIS, V73, P134, DOI 10.1053/j.ajkd.2018.05.008
  8. dos-Santos WLC, 2011, MEM I OSWALDO CRUZ, V106, P901, DOI 10.1590/S0074-02762011000700017
  9. D'Agati VD, 2013, CLIN J AM SOC NEPHRO, V8, P399, DOI 10.2215/CJN.06100612
  10. Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242
  11. Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388
  12. Mubarak Muhammed, 2012, World J Nephrol, V1, P35, DOI 10.5527/wjn.v1.i2.35
  13. Neves PDMM, 2016, KIDNEY INT, V89, P960, DOI 10.1016/j.kint.2015.12.015
  14. Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270
  15. Raja R, 2016, RENAL FAILURE, V38, P894, DOI 10.3109/0886022X.2016.1164063
  16. Riella C, 2019, KIDNEY INT REPORTS
  17. Santoriello D, 2018, KIDNEY INT, V94, P1189, DOI 10.1016/j.kint.2018.06.024
  18. Souza FPC, 2011, REV SOC BRAS CLIN ME, V9, P300
  19. Testagrossa Leonardo de Abreu, 2012, J. Bras. Patol. Med. Lab., V48, P211, DOI 10.1590/S1676-24442012000300009
  20. VANMARCK EAE, 1977, BRIT J EXP PATHOL, V58, P412

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/12
Carregar mais